Great-West Life Assurance Company »

Celldex Therapeutics shares owned by Great-West Life Assurance Company

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Great-West Life Assurance Company from 13F filings

Historical chart of Great-West Life Assurance Company investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Great-West Life Assurance Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Great-West Life Assurance Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $215k 6.3k 33.92
2024-06-30 $505k 14k 37.09
2024-03-31 $192k 4.6k 42.01
2023-12-31 $142k 3.6k 39.28
2023-09-30 $99k 3.6k 27.39
2023-06-30 $58k 1.7k 34.10
2023-03-31 $61k 1.7k 35.86
2022-12-31 $93k 2.1k 44.93
2022-09-30 $58k 2.1k 28.02
2022-06-30 $56k 2.1k 27.05
2022-03-31 $75k 2.1k 36.23
2021-12-31 $80k 2.1k 38.65
2021-09-30 $113k 2.1k 54.59
2021-06-30 $85k 2.6k 33.33
2021-03-31 $52k 2.6k 20.39
2020-12-31 $45k 2.6k 17.65